The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active

Celia Sequera; Margherita Grattarola; Floriane Cannet; Aurélie Dobric; Paula Michea Veloso; Melissa Methia; Sylvie Richelme; Abdessamad El Kaoutari; Paraskevi Kousteridou; Delphine Debayle; Lukas Kübler; Sandro Nuciforo; Yannick Boursier; Mathieu Dupont; Stefania Pizzimenti; Giuseppina Barrera; Jean-William Dupuy; Frédéric Saltel; Markus H. Heim; Sophie Vasseur; Xavier Adhoute; Fabienne Guillaumond; Jean-Paul Borg; Christian Morel; Flavio Maina

doi:10.1038/s41467-025-62934-0

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active

C Celia Sequera M Margherita Grattarola F Floriane Cannet A Aurélie Dobric P Paula Michea Veloso M Melissa Methia S Sylvie Richelme A Abdessamad El Kaoutari P Paraskevi Kousteridou D Delphine Debayle L Lukas Kübler S Sandro Nuciforo Y Yannick Boursier M Mathieu Dupont S Stefania Pizzimenti G Giuseppina Barrera J Jean-William Dupuy F Frédéric Saltel M Markus H. Heim S Sophie Vasseur X Xavier Adhoute F Fabienne Guillaumond J Jean-Paul Borg C Christian Morel F Flavio Maina

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Nature Communications

Volume / Issue Vol. 16, Issue 1

Published August 25, 2025

DOI 10.1038/s41467-025-62934-0

ISSN 2041-1723

Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (25)

C

Celia Sequera

M

Margherita Grattarola

F

Floriane Cannet

A

Aurélie Dobric

P

Paula Michea Veloso

M

Melissa Methia

S

Sylvie Richelme

A

Abdessamad El Kaoutari

P

Paraskevi Kousteridou

D

Delphine Debayle

L

Lukas Kübler

S

Sandro Nuciforo

Y

Yannick Boursier

M

Mathieu Dupont

S

Stefania Pizzimenti

G

Giuseppina Barrera

J

Jean-William Dupuy

F

Frédéric Saltel

M

Markus H. Heim

S

Sophie Vasseur

X

Xavier Adhoute

F

Fabienne Guillaumond

J

Jean-Paul Borg

C

Christian Morel

F

Flavio Maina

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active

Article Details

Journal Info

Authors (25)

Related Articles from this Journal

Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants

Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain